155 related articles for article (PubMed ID: 8800929)
21. Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands.
Baars MJ; Henneman L; ten Kate LP
Genet Test; 2004; 8(4):431-6. PubMed ID: 15684876
[TBL] [Abstract][Full Text] [Related]
22. Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population.
Poppelaars FA; Henneman L; Adèr HJ; Cornel MC; Hermens RP; van der Wal G; ten Kate LP
Genet Test; 2004; 8(2):80-9. PubMed ID: 15345102
[TBL] [Abstract][Full Text] [Related]
23. Risk perception after CF carrier testing and impact of the test result on reproductive decision making.
Denayer L; Welkenhuysen M; Evers-Kiebooms G; Cassiman JJ; Van den Berghe H
Am J Med Genet; 1997 Apr; 69(4):422-8. PubMed ID: 9098495
[TBL] [Abstract][Full Text] [Related]
24. What do young people think about screening for cystic fibrosis?
Cobb E; Holloway S; Elton R; Raeburn JA
J Med Genet; 1991 May; 28(5):322-4. PubMed ID: 1865469
[TBL] [Abstract][Full Text] [Related]
25. To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.
Vernooij-van Langen AM; Reijntjens S; van der Pal SM; Loeber JG; Dompeling E; Dankert-Roelse JE
Eur J Med Genet; 2013 Apr; 56(4):192-6. PubMed ID: 23352994
[TBL] [Abstract][Full Text] [Related]
26. Prenatal screening for cystic fibrosis: attitudes and responses of participants.
Mennie M; Compton M; Gilfillan A; Axton RA; Liston WA; Pullen I; Whyte D; Brock DJ
Clin Genet; 1993 Aug; 44(2):102-6. PubMed ID: 8275556
[TBL] [Abstract][Full Text] [Related]
27. Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening.
Faden RR; Tambor ES; Chase GA; Geller G; Hofman KJ; Holtzman NA
Am J Med Genet; 1994 Mar; 50(1):1-11. PubMed ID: 8160745
[TBL] [Abstract][Full Text] [Related]
28. An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests.
Castellani C; Perobelli S; Bianchi V; Seia M; Melotti P; Zanolla L; Assael BM; Lalatta F
Am J Med Genet A; 2011 Apr; 155A(4):778-85. PubMed ID: 21416590
[TBL] [Abstract][Full Text] [Related]
29. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.
Maxwell SJ; Kyne G; Molster C; Barker NM; Ormsby J; O'Leary P
Genet Test Mol Biomarkers; 2011 Mar; 15(3):159-64. PubMed ID: 21204697
[TBL] [Abstract][Full Text] [Related]
30. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
[No Abstract] [Full Text] [Related]
31. Attitudes of high school students toward carrier screening and prenatal diagnosis of cystic fibrosis.
Durfy SJ; Page A; Eng B; Chang PL; Waye JS
J Genet Couns; 1994 Jun; 3(2):141-55. PubMed ID: 11656674
[No Abstract] [Full Text] [Related]
32. What young people think and do when the option for cystic fibrosis carrier testing is available.
Mitchell J; Scriver CR; Clow CL; Kaplan F
J Med Genet; 1993 Jul; 30(7):538-42. PubMed ID: 8411024
[TBL] [Abstract][Full Text] [Related]
33. CF carrier testing in a high risk population: anxiety, risk perceptions, and reproductive plans of carrier by "non-carrier" couples.
Callanan NP; Cheuvront BJ; Sorenson JR
Genet Med; 1999; 1(7):323-7. PubMed ID: 11263543
[TBL] [Abstract][Full Text] [Related]
34. Psychological and social consequences of community carrier screening programme for cystic fibrosis.
Watson EK; Mayall ES; Lamb J; Chapple J; Williamson R
Lancet; 1992 Jul; 340(8813):217-20. PubMed ID: 1353144
[TBL] [Abstract][Full Text] [Related]
35. The views of general practitioners on community carrier screening for cystic fibrosis.
Boulton M; Cummings C; Williamson R
Br J Gen Pract; 1996 May; 46(406):299-301. PubMed ID: 8762747
[TBL] [Abstract][Full Text] [Related]
36. Attitudes and opinions of pregnant women who are not offered cystic fibrosis carrier screening.
Ioannou L; Massie J; Lewis S; Collins V; McClaren B; Delatycki MB
Eur J Hum Genet; 2014 Jul; 22(7):859-65. PubMed ID: 24253861
[TBL] [Abstract][Full Text] [Related]
37. Antenatal cystic fibrosis carrier screening--whether, when and how?
Miedzybrodzka Z; Haites N; Hall M; Templeton A; Marteau T; Dean J; Kelly K; Russell I
Paediatr Perinat Epidemiol; 1993 Oct; 7(4):368-75. PubMed ID: 8290376
[TBL] [Abstract][Full Text] [Related]
38. Disclosing to parents newborn carrier status identified by routine blood spot screening.
Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
[TBL] [Abstract][Full Text] [Related]
39. The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations.
Wilfond BS; Fost N
Milbank Q; 1992; 70(4):629-59. PubMed ID: 1435628
[TBL] [Abstract][Full Text] [Related]
40. Willingness to pay for antenatal carrier screening for cystic fibrosis.
Donaldson C; Shackley P; Abdalla M; Miedzybrodzka Z
Health Econ; 1995; 4(6):439-52. PubMed ID: 8653184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
